4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-081939
Chief Executive Officer sold 40,000 shares at an average $82.86 ($3,314,310)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BELANOFF JOSEPH K Chief Executive Officer | 2025-06-02 | Sale 10b5-1 | −4,881 | $78.42 | $382,773 | 2,937,104 | I |
| BELANOFF JOSEPH K Chief Executive Officer | 2025-06-02 | Sale 10b5-1 | −3,050 | $79.48 | $242,421 | 2,934,054 | I |
| BELANOFF JOSEPH K Chief Executive Officer | 2025-06-02 | Sale 10b5-1 | −2,988 | $80.30 | $239,941 | 2,931,066 | I |
| BELANOFF JOSEPH K Chief Executive Officer | 2025-06-02 | Sale 10b5-1 | −1,820 | $81.33 | $148,012 | 2,929,246 | I |
| BELANOFF JOSEPH K Chief Executive Officer | 2025-06-02 | Sale 10b5-1 | −1,263 | $82.26 | $103,899 | 2,927,983 | I |
| BELANOFF JOSEPH K Chief Executive Officer | 2025-06-02 | Sale 10b5-1 | −4,631 | $83.46 | $386,523 | 2,923,352 | I |
| BELANOFF JOSEPH K Chief Executive Officer | 2025-06-02 | Sale 10b5-1 | −12,959 | $84.57 | $1,095,962 | 2,910,393 | I |
| BELANOFF JOSEPH K Chief Executive Officer | 2025-06-02 | Sale 10b5-1 | −8,408 | $85.01 | $714,778 | 2,901,985 | I |
| Open-market sales · 40,000 sh · avg $82.86 · $3,314,310 | |||||||
Loading xslF345X05/ownership.xml…